Asahi Kasei Pharma (AHKSY.PK) Acquires Artisan Pharma, Inc. to Establish U.S. Presence; Wholly-owned Subsidiary Changes Name to Asahi Kasei Pharma America Corp.
11/22/2011 9:24:02 AM
More...
|
Artisan Pharma, Inc. Completes Enrollment in 750-patient Phase 2b Study of ART-123 in Sepsis Patients with DIC
4/29/2010 9:30:07 AM
More...
|
Artisan Pharma, Inc.'s Lead Product, ART-123, Approved in Japan
2/22/2008 8:32:25 AM
More...
|
Gary Shearman, Ph.D. Joins Board of Artisan Pharma, Inc.
10/22/2007 12:53:25 PM
More...
|
Artisan Pharma, Inc. And A-Bio Pharma Pte Ltd Announce Strategic Manufacturing Alliance on ART-123
9/18/2007 11:33:54 AM
More...
|
Artisan Pharma, Inc. Launches Phase 2b Trial of ART-123 for the Treatment of DIC in Sepsis
8/21/2007 10:42:32 AM
More...
|
Artisan Pharma, Inc. Hires Senior Clinical and Regulatory Management
2/26/2007 12:21:53 PM
More...
|
Artisan Pharma, Inc. Raises $39 Million In Series A Financing Led By NGN Capital LLC
9/6/2006 9:02:42 AM
More...
|